Point72 Hong Kong Ltd acquired a new position in shares of Metlife Inc (NYSE:MET) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 6,428 shares of the financial services provider’s stock, valued at approximately $328,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. FMR LLC grew its stake in Metlife by 1.6% during the fourth quarter. FMR LLC now owns 34,976,649 shares of the financial services provider’s stock worth $1,782,760,000 after buying an additional 554,242 shares during the period. AQR Capital Management LLC boosted its stake in shares of Metlife by 28.5% in the fourth quarter. AQR Capital Management LLC now owns 8,824,066 shares of the financial services provider’s stock valued at $449,586,000 after purchasing an additional 1,959,431 shares during the period. AJO LP boosted its stake in shares of Metlife by 26.2% in the fourth quarter. AJO LP now owns 3,682,448 shares of the financial services provider’s stock valued at $187,693,000 after purchasing an additional 765,110 shares during the period. Jennison Associates LLC boosted its stake in shares of Metlife by 2.6% in the fourth quarter. Jennison Associates LLC now owns 3,527,868 shares of the financial services provider’s stock valued at $179,815,000 after purchasing an additional 88,853 shares during the period. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its stake in shares of Metlife by 0.9% in the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,413,384 shares of the financial services provider’s stock valued at $173,980,000 after purchasing an additional 30,290 shares during the period. Institutional investors own 75.47% of the company’s stock.

MET has been the subject of several analyst reports. Morgan Stanley decreased their target price on shares of Metlife from $60.00 to $38.00 and set an “overweight” rating for the company in a research note on Tuesday, March 17th. Citigroup upgraded shares of Metlife from a “sell” rating to a “neutral” rating and decreased their target price for the company from $46.00 to $32.00 in a research note on Monday, March 16th. Wells Fargo & Co restated a “buy” rating on shares of Metlife in a research note on Monday, January 6th. ValuEngine upgraded shares of Metlife from a “strong sell” rating to a “sell” rating in a research note on Saturday, December 21st. Finally, Zacks Investment Research raised shares of Metlife from a “sell” rating to a “hold” rating and set a $52.00 price target on the stock in a report on Monday, December 9th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $46.80.

In other Metlife news, EVP Steven J. Goulart sold 14,200 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $51.60, for a total transaction of $732,720.00. Following the sale, the executive vice president now directly owns 127,130 shares of the company’s stock, valued at $6,559,908. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.31% of the stock is currently owned by corporate insiders.

MET traded up $2.13 during trading on Wednesday, hitting $29.74. The company had a trading volume of 13,539,013 shares, compared to its average volume of 7,901,167. The company has a market cap of $21.55 billion, a PE ratio of 4.92, a P/E/G ratio of 0.91 and a beta of 1.09. The business has a 50-day moving average of $42.02 and a 200-day moving average of $47.18. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.14 and a quick ratio of 0.14. Metlife Inc has a 1-year low of $22.85 and a 1-year high of $53.28.

Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.58. The firm had revenue of $18.15 billion for the quarter, compared to analysts’ expectations of $16.82 billion. Metlife had a net margin of 8.39% and a return on equity of 9.14%. The firm’s quarterly revenue was up 17.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.35 earnings per share. Research analysts forecast that Metlife Inc will post 6 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Tuesday, February 4th were issued a dividend of $0.44 per share. The ex-dividend date was Monday, February 3rd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 5.92%. Metlife’s dividend payout ratio (DPR) is 28.81%.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Story: Profit margin is different from the revenue

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.